Products for Research Use Only
RegisterLogin

Reozalimab

CAT: 0931-T80617-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T80617-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2445259-99-2
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation, Cell Cycle/Checkpoint, Apoptosis
Purity
0.981
Bioactivity
Reozalimab (LY3434172) is a bispecific monoclonal antibody targeting PD-1/PD-L1, inhibiting the primary inhibitory receptor-ligand interaction within the PD-1 pathway. It exhibits antitumour efficacy and enhances T-cell activation in vitro.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
BA6155-1Reozalimab
GTR18333924-01Reozalimab Antibody
HV974216-01Research Grade Reozalimab
E55B1292Reozalimab (Reference antibody)
GTR18697245-01Reozalimab Human Monoclonal Antibody
A135593Reozalimab Biosimilar (Monoclonal, Ig (G1-kappa_G1-lambda2) )
A4053Reozalimab (Ibi318) (Anti-PD-1 & PD-L1)
BIO1018SM-1mgAnti-human PD-1 & PD-L1 (Reozalimab Biosimilar)
PX-TA1879-01Reozalimab Biosimilar - Anti-PDCD1; CD274 mAb - Research Grade
GTR18699367-01Anti-PD-1 & PD-L1 Reference Antibody (Reozalimab Biosimilar)

Popular Products